ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
AzurRx BioPharma Announces Appointment of Daniel Schneiderman as Chief Financial Officer
January 05, 2020AzurRx BioPharma, Inc. (NASDAQ: AZRX) ("AzurRx" or the "Company"), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that Daniel Schneiderman has been appointed to serve as the
Pharma Sources Insight January 2025
